Advertisement

Topics

Cognition Therapeutics Inc. Company Profile

07:05 EDT 26th September 2017 | BioPortfolio

Cognition Therapeutics, Inc. is a leader in the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of diseases, and there are currently no therapeutics available to prevent or block the destructive effects of toxic oligomeric proteins. Cognition has leveraged its scientific expertise with these difficult targets to pioneer the use of proprietary assays that emphasize functional responses and proprietary medicinal chemistry that ensures novel, high quality small-molecule drug candidates for the treatment of these diseases.


News Articles [1657 Associated News Articles listed on BioPortfolio]

Cognition Therapeutics CEO Hosting One-On-Ones At

  Life Sciences Jobs   ...

Cognition Therapeutics CEO Kenneth I. Moch Hosting One-on-Ones at Mizuho Securities CNS Deep Management Day

PITTSBURGH, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alz...

Cognition Therapeutics CEO Kenneth I. Moch to Present at Ladenburg Thalmann 2017 Healthcare Conference

PITTSBURGH, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of A...

Cognition Therapeutics Elects Vice Chairman To Board Of Directors

  Life Sciences Jobs   ...

Function Of Cognition Therapeutics??? Neurological Drug Screening Platform Presented At American Chemical Society National Meeting

  Life Sciences Jobs   ...

Could Cannabis Help Preserve Brain Function As We Age?

Low-dose THC helped preserve cognition in aging mice. But it hurt cognition in young mice.

From the Helm Webinar Series from Cognition Corporation

Next Installments of Webinar Series Set for June 26 & 27. Lexington, Massachusetts (PRWEB) June 16, 2017 Cognition Corporation, a software company specializing in medical device compliance and co...

Cognition Therapeutics Reports Drug-Drug Interaction Results For CT1812, A Disease-Modifying Alzheimer???s Disease Candidate

  Life Sciences Jobs   ...

PubMed Articles [923 Associated PubMed Articles listed on BioPortfolio]

Chronic condition as a mediator between metabolic syndrome and cognition among community-dwelling older adults: The moderating role of sex.

Metabolic syndrome and chronic conditions are significant predictors of cognition; however, few studies have examined how they work together in predicting cognition in old age. Therefore, the present ...

Characterization of social cognition impairment in multiple sclerosis.

Multiple sclerosis (MS) has been associated with deficits in social cognition. However, little is known about which domains of social cognition are predominantly affected and what other factors are as...

Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.

While there is growing interest in the potential for intranasal oxytocin (IN-OT) to improve social cognition and neurocognition (ie, nonsocial cognition) in schizophrenia, the extant literature has be...

A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).

Schizophrenia is marked by a global cognitive impairment that contributes significantly to chronic disability and unemployment. As new treatments are developed for cognition in schizophrenia, clinicia...

Corrigendum to "Believe it or not: Moving non-biological stimuli believed to have human origin can be represented as human movement" Cognition 146 (2016) 431-438.

Clinical Trials [689 Associated Clinical Trials listed on BioPortfolio]

Effects of H1-Antagonist on Cognition

The purpose of this study is to determine whether histamine is involved in memory and specific processes in human cognition.

Efficacy of Social Cognition Training in Schizophrenia

The term social cognition refers to how social information is processed. Individuals with schizophrenia and schizoaffective disorder have been shown to have significant deficits in social ...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

The Impact of Family Financial Support on Cognition

We have partnered with financial coaching organizations to establish what we have termed a "Medical-Financial Partnership (MFP)" that offers financial coaching to improve financial and men...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [1164 Associated Companies listed on BioPortfolio]

Cognition Therapeutics Inc.

Cognition Therapeutics, Inc. is a leader in the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disea...

Cambridge Cognition Ltd

Cambridge Cognition Ltd specialises in computerised cognitive testing. Based in Cambridge, England, the company supplies products and services based on CANTAB®, the Cambridge Neuropsychological Test ...

MPI Cognition

Targacept

Targacept is a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics (TM), a new class of drugs for the treatment of central nervous system diseases and disorders. Targ...

Neuronascent, Inc

Neuronascent began operations in a fully functional cell culture facility in Maryland. Neuronascent is in the process of developing small-molecule therapeutics for Alzheimer’s disease and depression...

More Information about "Cognition Therapeutics Inc." on BioPortfolio

We have published hundreds of Cognition Therapeutics Inc. news stories on BioPortfolio along with dozens of Cognition Therapeutics Inc. Clinical Trials and PubMed Articles about Cognition Therapeutics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cognition Therapeutics Inc. Companies in our database. You can also find out about relevant Cognition Therapeutics Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record